HU9302728D0 - Pyridazinone-acetic acid derivatives - Google Patents
Pyridazinone-acetic acid derivativesInfo
- Publication number
- HU9302728D0 HU9302728D0 HU9302728A HU9302728A HU9302728D0 HU 9302728 D0 HU9302728 D0 HU 9302728D0 HU 9302728 A HU9302728 A HU 9302728A HU 9302728 A HU9302728 A HU 9302728A HU 9302728 D0 HU9302728 D0 HU 9302728D0
- Authority
- HU
- Hungary
- Prior art keywords
- pyridazinone
- acetic acid
- acid derivatives
- derivatives
- acetic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/14—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67691991A | 1991-03-28 | 1991-03-28 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HU9302728D0 true HU9302728D0 (en) | 1993-12-28 |
| HUT67836A HUT67836A (en) | 1995-05-29 |
Family
ID=24716565
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9302728A HUT67836A (en) | 1991-03-28 | 1992-03-09 | Pyridazinone acetic acids having aldose reductase inhibitory activity, pharmaceutical compositions containing them and process for preparation of them |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0582643A1 (en) |
| JP (1) | JPH06500793A (en) |
| CN (1) | CN1065269A (en) |
| AU (1) | AU658887B2 (en) |
| BR (1) | BR9205810A (en) |
| CA (1) | CA2107104A1 (en) |
| CZ (1) | CZ387092A3 (en) |
| DE (1) | DE9290035U1 (en) |
| FI (1) | FI934222A0 (en) |
| HU (1) | HUT67836A (en) |
| IE (1) | IE920979A1 (en) |
| IL (1) | IL101325A0 (en) |
| MX (1) | MX9201414A (en) |
| NZ (1) | NZ242152A (en) |
| PT (1) | PT100301A (en) |
| TW (1) | TW207998B (en) |
| WO (1) | WO1992017446A2 (en) |
| YU (1) | YU30392A (en) |
| ZA (1) | ZA922238B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2240657T3 (en) | 2001-02-28 | 2005-10-16 | Pfizer Products Inc. | SULFONILPIRIDAZINONA COMPOUNDS USEFUL AS INHIBITORS OF ALDOSA REDUCTASA. |
| SE0100873D0 (en) * | 2001-03-13 | 2001-03-13 | Astrazeneca Ab | Method of treatment |
| AU2002226634B2 (en) | 2001-03-30 | 2007-01-25 | Pfizer Products Inc. | Pyridazinone aldose reductase inhibitors |
| AU761191B2 (en) * | 2001-05-24 | 2003-05-29 | Pfizer Products Inc. | Therapies for tissue damage resulting from ischemia |
| US7572910B2 (en) | 2003-02-20 | 2009-08-11 | Pfizer, Inc. | Pyridazinone aldose reductase inhibitors |
| CN111617072B (en) * | 2019-02-27 | 2023-06-20 | 苏州凯祥生物科技有限公司 | Hyperuricemia medicine composition and medicine for treating hyperuricemia |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0676391B2 (en) * | 1987-06-09 | 1994-09-28 | フアイザー・インコーポレイテツド | Process for producing oxophthalazinyl acetic acid having heterocyclic side chain such as benzothiazole |
| FR2647676A1 (en) * | 1989-06-05 | 1990-12-07 | Union Pharma Scient Appl | New pyridazinone derivatives, processes for preparing them and medicaments containing them which are useful, in particular, as aldose reductase inhibitors |
-
1992
- 1992-03-09 BR BR9205810A patent/BR9205810A/en not_active Application Discontinuation
- 1992-03-09 DE DE9290035U patent/DE9290035U1/en not_active Expired - Lifetime
- 1992-03-09 CZ CS923870A patent/CZ387092A3/en unknown
- 1992-03-09 JP JP4509938A patent/JPH06500793A/en active Pending
- 1992-03-09 HU HU9302728A patent/HUT67836A/en unknown
- 1992-03-09 EP EP92910955A patent/EP0582643A1/en not_active Withdrawn
- 1992-03-09 AU AU17796/92A patent/AU658887B2/en not_active Ceased
- 1992-03-09 WO PCT/US1992/001603 patent/WO1992017446A2/en not_active Application Discontinuation
- 1992-03-09 CA CA002107104A patent/CA2107104A1/en not_active Abandoned
- 1992-03-13 TW TW081101914A patent/TW207998B/zh active
- 1992-03-22 IL IL101325A patent/IL101325A0/en unknown
- 1992-03-26 PT PT100301A patent/PT100301A/en not_active Application Discontinuation
- 1992-03-26 YU YU30392A patent/YU30392A/en unknown
- 1992-03-27 NZ NZ24215292A patent/NZ242152A/en unknown
- 1992-03-27 MX MX9201414A patent/MX9201414A/en unknown
- 1992-03-27 ZA ZA922238A patent/ZA922238B/en unknown
- 1992-03-27 CN CN92102224A patent/CN1065269A/en active Pending
- 1992-03-27 IE IE097992A patent/IE920979A1/en not_active Application Discontinuation
-
1993
- 1993-09-27 FI FI934222A patent/FI934222A0/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1065269A (en) | 1992-10-14 |
| WO1992017446A3 (en) | 1992-11-26 |
| IL101325A0 (en) | 1992-11-15 |
| HUT67836A (en) | 1995-05-29 |
| ZA922238B (en) | 1993-09-27 |
| WO1992017446A2 (en) | 1992-10-15 |
| PT100301A (en) | 1993-06-30 |
| MX9201414A (en) | 1992-10-01 |
| AU658887B2 (en) | 1995-05-04 |
| BR9205810A (en) | 1994-06-28 |
| JPH06500793A (en) | 1994-01-27 |
| YU30392A (en) | 1994-11-15 |
| CA2107104A1 (en) | 1992-09-29 |
| FI934222A (en) | 1993-09-27 |
| CZ387092A3 (en) | 1994-02-16 |
| AU1779692A (en) | 1992-11-02 |
| NZ242152A (en) | 1994-07-26 |
| DE9290035U1 (en) | 1993-11-18 |
| FI934222A0 (en) | 1993-09-27 |
| TW207998B (en) | 1993-06-21 |
| IE920979A1 (en) | 1992-10-07 |
| EP0582643A1 (en) | 1994-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA924743B (en) | 7-azaisoindolinyl-quinolone-and-naphthyrindonecarboxylic acid derivatives | |
| AP9200447A0 (en) | Acetic acid derivatives | |
| PH30227A (en) | 7-Isoindolinyl-quinolone-carboxylic acid derivatives | |
| HU9400143D0 (en) | Quinolon-and naphtiridon-carboxylic acid derivatives | |
| IL103538A0 (en) | Quinoxaline-carboxylic and-phosphonic acid derivatives | |
| HU9203123D0 (en) | Substituted imidazolyl-propenic acid derivatives | |
| ZA93190B (en) | Benzofuranyl- and thiophenylmethylthio-alkanecarboxylic acid derivatives | |
| AU646762B2 (en) | Cyclic-substituted imidazolyl-propenoic acid derivatives | |
| HU9203124D0 (en) | Imidazolyl-propenic acid derivatives | |
| HU9403116D0 (en) | Epoxy-succinic acid derivatives | |
| ZA911398B (en) | Carboxylic acid derivatives | |
| ZA929330B (en) | Thiazolyl-substituted quinolylmethoxyphenylacetic acid derivatives. | |
| ZA913132B (en) | Carboxylic acid derivatives | |
| HU9302728D0 (en) | Pyridazinone-acetic acid derivatives | |
| ZA941668B (en) | Acyloxyhexanoic acid derivatives | |
| ZA931367B (en) | Sulphonylbenzyl-substituted imidazolylpropenoic acid derivatives | |
| AP9200396A0 (en) | Propenoic acid derivatives | |
| ZA928275B (en) | Quinoxaline-carboxylic and -phosphonic acid derivatives. | |
| IL110170A0 (en) | 2-Oximino-2-thienyl-acetic acid derivatives | |
| ZA93125B (en) | Quinolone- and naphthyridone-carboxylic acid derivatives | |
| ZA941923B (en) | Phenoxyphenylacetic acid derivatives | |
| ZA922831B (en) | Novel thienyl-nonatetraenoic acid derivatives | |
| HU9400588D0 (en) | 3-hydroxyanthranilic acid derivatives | |
| ZA924932B (en) | 4-amino-3-hydroxycarboxylic acid derivatives | |
| ZA924515B (en) | 7-isoindolinyl-quinolone-and naphthyridonecarboxylic acid derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DFD9 | Temporary protection cancelled due to non-payment of fee |